The 26th Annual Scientific Conference of Alexandria Clinical Oncology Department took place from 15th to 17th November at Bibliotheca Alexandria, a renowned venue for intellectual gatherings. This highly anticipated event revolved around the theme of “Cancer Management Gaps and Goals in the Presence of International Speakers,” aiming to provide attendees with a comprehensive understanding of the latest advancements in cancer research and treatment. Throughout the conference, a diverse range of topics were explored, covering various aspects of oncology and its multidisciplinary approach.

One of the focal points of the conference was shedding light on the best Egyptian oncology centers, showcasing the remarkable progress made in the field within the country. This served as an opportunity to recognize the efforts of these centers in delivering exceptional care to cancer patients and furthering the development of oncology in Egypt.

In addition to this, the conference delved into the realm of radiotherapy, a vital component of cancer treatment. Experts in the field shared their insights on the latest techniques and advancements in radiotherapy, highlighting its crucial role in improving patient outcomes and quality of life.

Artificial intelligence (AI) also emerged as an important topic during the conference. Presentations and discussions centered around the integration of AI in oncology, exploring its potential to revolutionize cancer diagnosis, treatment planning, and patient monitoring. The transformative power of AI in the field of oncology was emphasized, with experts envisioning a future where AI-driven technologies play a pivotal role in personalized cancer care.

Nuclear medicine, another significant aspect of cancer management, was extensively covered during the conference. Experts presented the latest developments in nuclear medicine techniques, such as positron emission tomography (PET) scans and targeted radionuclide therapy. These advancements showcased the potential of nuclear medicine in improving cancer detection, staging, and treatment.

The conference also dedicated sessions to exploring the dynamic between oncologists and cancer patients. Recognizing the importance of a strong doctor-patient relationship, experts discussed effective communication strategies, shared decisionmaking processes, and the psychological support needed for cancer patients throughout their journey. This highlighted the significance of a holistic approach to cancer care, where patients’ emotional well-being is given equal importance alongside medical interventions.

“I would also like to take this opportunity to express my sincere appreciation to Dr. Abdelaziz Konsowa for his dedication and contributions to the success of this conference. His efforts have been invaluable and have greatly enriched our experience. Furthermore, I am delighted to celebrate and acknowledge the remarkable achievements accomplished throughout the year. It is with great pride that I announce the 26th anniversary of this esteemed conference”, quoted Prof. Yosuri Rostom, Conference President

Furthermore, the conference addressed several other crucial topics in oncology. Advances in early breast cancer were explored, focusing on the latest research findings and treatment options for this aggressive subtype of breast cancer. The role of anthracyclines, a class of chemotherapy drugs, in early breast cancer was also discussed, providing insights into their efficacy and potential side effects.

The Egyptian national health strategy was a key area of focus, with experts presenting an overview of the country’s approach to cancer prevention, early detection, and treatment. This comprehensive strategy aimed to address the unique challenges faced by Egypt in combating cancer and improving patient outcomes.

The conference also dedicated sessions to specific types of cancer, including lung, pediatric, and gynecological cancer. Experts shared updates on the latest advancements in these areas, ranging from novel treatment modalities to emerging research findings. The management of cancer cervix, a significant concern in women’s health, was also discussed, providing attendees with valuable insights into the latest guidelines and approaches for its diagnosis and treatment.

900+ Attendees had the opportunity to gain valuable knowledge from international speakers and experts in the field, equipping them with the latest information and advancements in cancer research and treatment.

During the conference, there was also a focus on the importance of palliative care in cancer treatment. Experts discussed the role of palliative care in improving the quality of life for patients with advanced cancer, emphasizing the need for early integration of these services. Additionally, the conference highlighted the emerging field of precision medicine in oncology, showcasing the potential of personalized treatment approaches based on a patient’s unique genetic profile. These discussions shed light on the future of cancer care and the potential for more targeted and effective therapies.